Clinical Trial Update: Study Assessing the Safety and Therapeutic Effect of Buprenorphine in MDD Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update assessing the safety and potential therapeutic effect of buprenorphine in patients with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Shalvata Mental Health Center | Conditions: Depression | Phase 1 | Status: UNKNOWN